ArticleCardiovascular drugs and therapy2024

Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation.

Xiaoye Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.